Generare

Private

ParisHealthcare & Life Scienceshttps://generare.bio/

Last Round

Series A

Apr 2, 2026

Total Funding Raised

$28.4M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Generare is a biotechnology company that has developed a data-driven discovery platform to identify novel bioactive molecules from microbes for applications in medicine and other industries.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

drug discoverysynthetic biologybioactive moleculesbiotech R&Dgenome mininglead optimizationcomputational biologybiosynthetic gene clustersbiotech platformdrug discovery platformin silico drug discoveryai drug discoverynatural product discoverybiotech partnershipdata as a service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Generare Comps

Public and private peers based on sector, stage, and business model.

Generare comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Generare Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Apr 2, 2026
Seed	Oct 8, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Guillaume Vandenesch

CEO Co-founder

Founding Team

Generare Investors

Notable investors and investment history

Generare investors
Investor	Rounds
Saras Capital	Seed
Alven	Series A
SynBioVen	Seed
Daphni	Series A
Galion.exe	Series A, Seed
VIVES Partners	Series A, Seed
Better Angle	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 2, 2026
$23M round completed.
Oct 8, 2024
$5.5M raised in Seed round.

View all signals

Generare Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Generare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Generare's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis

Employee Range36

Year Founded2023

Last FundingApr 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.